Skip to main content

Survey Identifies Ideal Male Buttock Aesthetic

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 3, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 3, 2024 -- Both men and women favor a more projected male buttock with a more pronounced contour, according to a study published in the December issue of Plastic and Reconstructive Surgery.

Tejas Kollu, from Albany Medical Center in New York, and colleagues surveyed 2,095 adults (61 percent male) to define the ideal male buttocks. Respondents rated a panel of digitally altered male buttocks from most to least attractive using three views.

The researchers found that the preferred lateral ratio in the anteroposterior dimension was 1.18; the oblique angle between the sacrum, lateral gluteal depression, and point of maximal projection of the gluteal sulcus was 60 degrees; and the posterior ratio between the waist and maximal width of the hips was 0.66. These preferences correspond to moderate gluteal projection in the lateral and oblique views, with a narrower gluteal width, and defined trochanteric depression in the posterior view. Lower scores were seen with loss of the trochanteric depression. Differences in preferences were seen by region, race, sexual orientation, employment industry, and athletic interest, but not sex.

"These findings have the potential to guide future aesthetic gluteal contouring techniques in men," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.